APA (7th ed.) Citation

Fang, M., Cheng, J., Chen, Y., Lin, X., Su, J., Wu, Y., . . . Yang, J. (2024, March). Molecular features and clinical outcomes of EGFR-mutated, MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy. Therapeutic Advances in Medical Oncology.

Chicago Style (17th ed.) Citation

Fang, Mei-Mei, Jiang-Tao Cheng, Yu-Qing Chen, Xiao-Cheng Lin, Jun-Wei Su, Yi-Long Wu, Hua-Jun Chen, and Jin-Ji Yang. "Molecular Features and Clinical Outcomes of EGFR-mutated, MET-amplified Non-small-cell Lung Cancer After Resistance to Dual-targeted Therapy." Therapeutic Advances in Medical Oncology Mar. 2024.

MLA (9th ed.) Citation

Fang, Mei-Mei, et al. "Molecular Features and Clinical Outcomes of EGFR-mutated, MET-amplified Non-small-cell Lung Cancer After Resistance to Dual-targeted Therapy." Therapeutic Advances in Medical Oncology, Mar. 2024.